{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T23:46:39Z","timestamp":1790552799113,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,10]],"date-time":"2008-04-10T00:00:00Z","timestamp":1207785600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10461-008-9382-4","type":"journal-article","created":{"date-parts":[[2008,4,9]],"date-time":"2008-04-09T15:40:56Z","timestamp":1207755656000},"page":"33-41","source":"Crossref","is-referenced-by-count":12,"title":["Adherence to Both Cotrimoxazole and Placebo is Associated with Improved Survival Among HIV-Infected Zambian Children"],"prefix":"10.1007","volume":"13","author":[{"given":"A. Sarah","family":"Walker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Mulenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret J.","family":"Thomason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chifumbe","family":"Chintu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Bangsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,4,10]]},"reference":[{"key":"9382_CR1","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","volume":"353","author":"X. Anglaret","year":"1999","unstructured":"Anglaret, X., Chene, G., Attia, A., Toure, S., Lafont, S., Combe, P., et al. (1999). Early chemoprophylaxis with trimethtoprim\u2013sulphamethoxazole for HIV-1 infected adults in Abidjan, Cote d\u2019Ivoire: A randomised trial. The Lancet, 353, 1463\u20131468.","journal-title":"The Lancet"},{"key":"9382_CR2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0140-6736(05)75237-5","volume":"354","author":"M. Badri","year":"1999","unstructured":"Badri, M., Maartens, G., Wood, R., & Ehrlich, R. (1999). Co-trimoxazole in HIV-1 infection. The Lancet, 354, 334\u2013335.","journal-title":"The Lancet"},{"key":"9382_CR3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/00002030-200106150-00015","volume":"15","author":"D. R. Bangsberg","year":"2001","unstructured":"Bangsberg, D. R., Perry, S., Charlebois, E. D., Clark, R. A., Robertson, M., Zolopa, A. R., et al. (2001). Nonadherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS, 15, 1181\u20131183.","journal-title":"AIDS"},{"key":"9382_CR4","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1007\/s10461-006-9141-3","volume":"10","author":"W. Bikaako-Kajura","year":"2006","unstructured":"Bikaako-Kajura, W., Luyirika, E., Purcell, D. W., Downing, J., Kaharuza, F., Mermin, J., et al. (2006). Disclosure of HIV status and adherence to daily drug regimens among HIV-infected children in Uganda. AIDS & Behavior, 10, S85\u2013S93.","journal-title":"AIDS & Behavior"},{"key":"9382_CR5","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/S0140-6736(04)17442-4","volume":"364","author":"C. Chintu","year":"2004","unstructured":"Chintu, C., Bhat, G. J., Walker, A. S., Mulenga, V., Sinyinza, F., Lishimpi, K., et al. (2004). Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): A double-blind randomized placebo-controlled trial. The Lancet, 364, 1865\u20131871.","journal-title":"The Lancet"},{"key":"9382_CR6","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-199806010-00003","volume":"18","author":"L. J. Eldred","year":"1998","unstructured":"Eldred, L. J., Wu, A. W., Chaisson, R. E., & Moore, R. D. (1998). Adherence to antretroviral and pneumocystis prophylaxis in HIV disease. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, 18, 117\u2013125.","journal-title":"Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology"},{"key":"9382_CR7","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1086\/520433","volume":"29","author":"W. M. El-Sadr","year":"1999","unstructured":"El-Sadr, W. M., Luskin-Hawk, R., Yurik, T. M., Walker, J., Abrams, D., John, S. L., et al. (1999). A randomized trial of daily and thrice-weekly trimethoprim\u2013sulfamethoxazole for the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected persons. Clinical Infectious Diseases, 29, 775\u2013783.","journal-title":"Clinical Infectious Diseases"},{"key":"9382_CR8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/adc.73.1.17","volume":"73","author":"J. V. Freeman","year":"1995","unstructured":"Freeman, J. V., Cole, T. J., Chinn, S, Jones, P. R. M., White, E. M., & Preece, M. A. (1995). Cross sectional stature and weight reference curves for the UK, 1990. Archives of Disease in Childhood, 73, 17\u201324.","journal-title":"Archives of Disease in Childhood"},{"key":"9382_CR9","doi-asserted-by":"crossref","unstructured":"Gibb, D. M., Goodall, R. L., Giacomet, V., McGee, L., Compagnucci, A., & Lyall, H., Paediatric European Network for Treatment of AIDS Steering Committee. (2003). Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial. Pediatric Infectious Disease Journal, 22, 56\u201362.","DOI":"10.1097\/00006454-200301000-00015"},{"key":"9382_CR10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00002030-200501280-00008","volume":"19","author":"K. Grimwade","year":"2005","unstructured":"Grimwade, K., Sturm, A. W., Nunn, A. J., Mbatha, D., Zungu, D., & Gilks, C. F. (2005). Effectiveness of cotrimoxazole on mortality in adults with tuberculosis in rural South Africa. AIDS, 19, 163\u2013168.","journal-title":"AIDS"},{"key":"9382_CR11","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/sim.4780131007","volume":"13","author":"K. R. Hess","year":"1994","unstructured":"Hess, K. R. (1994). Assessing time-by-covariate interactions in proportional hazards regression models using cubic spline functions. Statistics in Medicine, 13, 1045\u20131062.","journal-title":"Statistics in Medicine"},{"key":"9382_CR12","first-page":"1","volume":"48","author":"J. L. Jones","year":"1999","unstructured":"Jones, J. L., Hanson, D. L., Dworkin, M. S., Alderton, D. L., Fleming, P. L., Kaplan, J. E., et al. (1999). Surveillance for AIDS-defining opportunistic illnesses, 1992\u20131997. Morbidity & Mortality Weekly Report. Surveillance Summaries, 48, 1\u201322.","journal-title":"Morbidity & Mortality Weekly Report. Surveillance Summaries"},{"key":"9382_CR13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0895-7061(96)00056-8","volume":"9","author":"J. Y. Lee","year":"1996","unstructured":"Lee, J. Y., Kusek, J. W., Greene, P. G., Bernhard, S., Norris, K., Smith, D., et al. (1996). Assessing medication adherence by pill count and electronic monitoring in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. American Journal of Hypertension, 9, 719\u2013725.","journal-title":"American Journal of Hypertension"},{"key":"9382_CR14","doi-asserted-by":"crossref","unstructured":"Liu, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandaji, S., et\u00a0al. (2001). A comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968\u2013977. Erratum in: Annals of Internal Medicine, 136, 175, 2002.","DOI":"10.7326\/0003-4819-134-10-200105150-00011"},{"key":"9382_CR15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1086\/339074","volume":"34","author":"S. Mannheimer","year":"2002","unstructured":"Mannheimer, S., Friedland, G., Matts, J., Child, C., & Chesney, M. (2002). The consistency of adherence to antiretroviral therapy predicts biologic outcomes for human immunodeficiency virus-infected persons in clinical trials. Clinical Infectious Diseases, 34, 1115\u20131121.","journal-title":"Clinical Infectious Diseases"},{"key":"9382_CR16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.inf.0000250625.80340.48","volume":"26","author":"S. Martin","year":"2007","unstructured":"Martin, S., Elliott-DeSorbo, D. K., Wolters, P. L., Toledo-Tamula, M. A., Roby, G., Zeichner, S., et al. (2007). Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents. Pediatric Infectious Disease Journal, 26, 61\u201367.","journal-title":"Pediatric Infectious Disease Journal"},{"key":"9382_CR17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/j.1552-4604.1994.tb04009.x","volume":"34","author":"D. Matsui","year":"1994","unstructured":"Matsui, D., Hermann, C., Klein, J., Berkovitch, M., Olivieri, N., & Koren, G. (1994). Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator. Journal of Clinical Pharmacology, 34, 944\u2013949.","journal-title":"Journal of Clinical Pharmacology"},{"key":"9382_CR19","first-page":"576","volume-title":"Forfar and Arnneil\u2019s textbook of paediatrics","author":"N. McIntosh","year":"2003","unstructured":"McIntosh, N., Helms, P., & Smyth, R. (2003) Forfar and Arnneil\u2019s textbook of paediatrics (6th ed., pp. 576\u2013577). London: Churchill Livingstone.","edition":"6"},{"key":"9382_CR18","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-200308150-00005","volume":"17","author":"J. J. McNabb","year":"2003","unstructured":"McNabb, J. J., Nicolau, D. P., Stoner, J. A., & Ross, J. (2003). Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS, 17, 1763\u20131767.","journal-title":"AIDS"},{"key":"9382_CR20","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(04)17225-5","volume":"364","author":"J. Mermin","year":"2004","unstructured":"Mermin, J., Lule, J., Ekwaru, J. P., Malamba, S., Downing, R., Ransom, R., et al. (2004). Effect of cotrimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. The Lancet, 364, 1428\u20131434.","journal-title":"The Lancet"},{"issue":"11","key":"9382_CR21","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1371\/journal.pmed.0030438","volume":"3","author":"E. J. Mills","year":"2006","unstructured":"Mills, E. J., Nachega, J. B., Bangsberg, D. R., Singh, S., Rachlis, B., Wu, P., et al. (2006). Adherence to HAART; a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Medicine, 3(11), e438.","journal-title":"PLoS Medicine"},{"key":"9382_CR22","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1086\/424008","volume":"39","author":"A. R. Moss","year":"2004","unstructured":"Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., et al. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39, 1190\u20131198.","journal-title":"Clinical Infectious Diseases"},{"issue":"7557","key":"9382_CR23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.38875.675486.55","volume":"333","author":"S. H. Simpson","year":"2006","unstructured":"Simpson, S. H., Eurich, D. T., Majumdar, S. R., Padwal, R. S., Tsuyuki, R. T., Varney, J., et al. (2006). A meta-analysis of the association between adherence to drug therapy and mortality. British Medical Journal, 333(7557):15.","journal-title":"British Medical Journal"},{"key":"9382_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.qai.0000226334.34717.dc","volume":"42","author":"A. S. Walker","year":"2006","unstructured":"Walker, A. S., Mulenga, V., Sinyinza, F., Lishimpi, K., Nunn, A., Chintu, C., et al. (2006). Determinants of survival without antiretroviral therapy after infancy in HIV-1-infected Zambian children in the CHAP trial. Journal of Acquired Immune Deficiency Syndromes, 42, 637\u2013645.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9382_CR25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1200\/JCO.1993.11.6.1189","volume":"11","author":"D. M. Waterhouse","year":"1993","unstructured":"Waterhouse, D. M., Calzone, K. A., Mele, C., & Brenner, D. E. (1993). Adherence to oral tamoxifen: A comparison of patient self-report, pill counts and microelectronic monitoring. Journal of Clinical Oncology, 11, 1189\u20131197.","journal-title":"Journal of Clinical Oncology"},{"key":"9382_CR26","unstructured":"Wiktor, S. Z., Sassan-Morroko, M., Grant, A. D., Abouya, L., Karon, J. M., Maurice, C., et\u00a0al. (1999). Efficacy of trimethoprim\u2013sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1 infected patients with tuberculosis in Abidjan, Cote d\u2019Ivoire: A randomised controlled trial. The Lancet, 353, 1469\u20131475. Erratum in: The Lancet, 353, 2078, 1999."},{"key":"9382_CR27","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/01.aids.0000226951.49353.ed","volume":"20","author":"E. Wood","year":"2006","unstructured":"Wood, E., Hogg, R. S., Yip, B., Moore, D., Harrigan, P. R., & Montaner, J. S. (2006). Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or =200\u00a0cells\/microl. AIDS, 20, 1117\u20131123.","journal-title":"AIDS"},{"key":"9382_CR28","unstructured":"World Health Organization. (2006). Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults in resource-limited settings: Recommendations for a public health approach. Retrieved from http:\/\/www.womenchildrenhiv.org . Accessed 31 Mar 2008."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-008-9382-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-008-9382-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-008-9382-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T13:27:30Z","timestamp":1559136450000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-008-9382-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,10]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["9382"],"URL":"https:\/\/doi.org\/10.1007\/s10461-008-9382-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,10]]}}}